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Abstract The tetracycline resistance gene (tetA) was cloned 
downstream of the lac promoter. When expression of the tetA 
gene in E. coli cells carrying the lac I q gene was induced with 
isopropyl/]-D-thiogalactopyranoside, the tetracycline resistance 
protein (TetA) was overproduced, amounting to about 30% of the 
integral cytoplasmic membrane protein. Essentially pure TetA 
protein could be obtained by solubilization with 1.25% n-octyl-/]- 
o-glucopyranoside and one-step urification by DEAE Sepharose 
CL-6B column chromatography. The TetA protein was incorpo- 
rated into proteoliposomes with FoF1-ATPase. The proteo- 
liposomes exhibited [3HItetracycline transport dependent on ATP 
hydrolysis. The specific activity was about 2 nmol/mg protein/ 
min. The proteoliposomes also showed H+ efflux coupled with 
tetracycline influx. Tetracycline/H* antiport by proteo- 
liposomes reconstituted with the Set-65 --~ Cys mutant TetA pro- 
tein was inhibited by N-ethylmaleimide. These results proved for 
the first time that the tetracycline/H* antiport is only mediated 
by the TetA protein. 
Key words: Tetracycline; Antiporter; Tetracycline/H + 
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1. Introduction 
The metal-tetracycline/H + antiporter (TetA) [1,2] encoded by 
transposon Tn 10 is the cytoplasmic membrane protein respon- 
sible for high level tetracycline resistance in Gram-negative 
bacteria [3,4]. It is composed of 401 amino acid residues [5,6]. 
Based on the hydropathy profile of its amino acid sequence, 
and the results of protease digestion [7] and antibody binding 
[8], a secondary structure model has been proposed in which 
the TetA protein consists of 12 transmembrane s gments, con- 
nected by 11 hydrophilic loops, with the N- and C-terminals on 
the cytoplasmic surface. Recent studies on a series of pBR322- 
encoded TetA-alkaline phosphatase fusions also supported 
such a structure [9]. Through our site-directed mutagenesis 
studies [10 17], several amino acid residues essential or impor- 
tant for substrate translocation and/or H + translocation have 
been identified. However, because of a lack of information on 
its three-dimensional structure, the spatial and functional rela- 
tionships of these residues remain unknown. Therefore, the 
purification of and a reconstitution system for the TetA protein 
are obligatory. 
Despite its deleterious effect [18], some attempts to overpro- 
duce the TetA protein have been made [18-20]. Hickman et al. 
[19] constructed a clone in which the tetA gene was placed 
downstream of the 2PL promoter, but the overproduction was 
unsuccessful. Alternatively, they overproduced a TetA-colla- 
gen-fl-galactosidase fusion protein. After collagenase digestion 
of the purified fusion protein, the TetA protein was purified, 
but transport activity was not observed [19]. Eckert and Beck 
[18] also cloned the tetA gene behind the tac promoter. How- 
ever, overproduction of the TetA protein was not detected, 
probably due to its lethal effect [18,20]. We also attempted to 
construct a TetA overproducing system in which the tetA gene 
is located ownstream of the lac promoter in a multicopy plas- 
mid vector in a previous study [21], The use of E. coli cells 
carrying the constitutive lac repressor gene enabled us to over- 
produce the TetA protein [21]. This system is very useful for the 
purification and reconstitution of the functional TetA protein. 
In order to assay the active tetracycline transport into recon- 
stituted proteoliposomes, it is necessary to produce an interior- 
acidic proton gradient as a driving force. An artificial ApH 
imposed through ionophore-mediated K+/H ÷ exchange is too 
weak and transient o drive tetracycline/H + antiport even in 
inverted membrane vesicles [22]. Recently, Moriyama et al. [23] 
used FoF~-ATPase for the reconstitution of active transport of 
neurotransmitter transporters. ATP hydrolysis by FoF~-ATP- 
ase in proteoliposomes provides a large and durable interior- 
acidic proton gradient, which is adequate as a driving force for 
tetracycline/H + antiport in reconstituted proteoliposomes. 
This is the first report of the functional reconstitution of a 
metal-tetracycline/H + antiporter using FoF~-ATPase as an en- 
ergy generator. Reconstituted proteoliposomes xhibited ATP- 
dependent tetracycline/H + antiport. 
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Abbreviations." TetA, tetracycline r sistance protein; MOPS, 3-(N-mor- 
pholino)propanesulfonic acid; MES, 2-(N-morpholino)ethanesulfonic 
acid; tricine, N-tris(hydroxymethyl)methylglycine; octylglucoside, n-
octyl-fl-D-glucopyranoside; NEM, N-ethylmaleimide; TC, tetracycline. 
2. Materials and methods 
2.1. Materials 
[7-3H(N)]Tetracycline was purchased from Du Pont-New England 
Nuclear. DEAE-Sepharose CL-6B was from Pharmacia. Soybean L-a- 
phosphatidylcholine (type II-S) was from Sigma. All other chemicals 
were of reagent grade and obtained from commercial sources. 
2.2. E. coli strains and plasmids 
E. coli RB791 (W3110 laclqL8) [24] was used as the host strain for 
plasmids pSYTET and pSYS65C, which carry the wild-type and Cys65 
mutant etA genes [10], respectively, downstream of the lac promoter 
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[21]. E. coli DK8 (AuncB-C, ilv::TnlO) [25] harboring plasmid 
pBWUI3 carrying the entire unc operon [23] was also used. 
2.3. Preparation of E. coli phospholipids and FoFI-ATPase 
E. coli RB791 cells were grown at 37°C on minimal medium supple- 
mented with 0.2% glucose and 0.1% casamino acids. Phospholipids 
were extracted according to Bligh and Dyer [26], suspended in 2 mM 
fl-mercaptoethanol at 50 mg of lipid/ml, and stored at -20°C. FoF~- 
ATPase was prepared by one-step purification from E. coli DKS/ 
pBWUI3 cells [23]. 
2.4. Cell fractionation and EDTA-treatment of inner rnembranes 
E. coli RB791 cells harboring plasmid pSYTET or pSYS65C were 
grown at 37°C on minimal medium supplemented with 0.2% glucose 
and 0.1% casamino acids. Expression of the tetA gene was induced with 
0.1 mM isopropyl fl-D-thiogalactopyranoside at the late log phase. 
After 2 h, the cells were harvested, and lysed by passage through a 
French pressure cell at 10,000 psi in 50 mM MOPS-KOH (pH 7.0) 
containing 10 mM MgC12, 0.5 mM EDTA, 0.5 mM phenylmethylsul- 
fonyl fluoride, 5% glycerol and 10 pg/ml deoxyribonuclease I at 4°C. 
All manipulations were performed at 4°C. French press vesicles were 
suspended in 50 mM MOPS-KOH (pH 7.0) containing 0.5 mM EDTA, 
1 mM dithiothreitol, 0.5 mM phenylrnethylsulfonyl fluoride and 5% 
glycerol. The inner membrane fraction of French press vesicles was 
separated from the outer membrane fraction by sucrose density gradi- 
ent centrifugation [23,27], and then washed with 1 mM MES-Tricine 
(pH 7.0) containing 0.5 mM EDTA, 5 mM monothioglycerol and 10% 
glycerol, suspended in 10 mM MES-Tricine (pH 7.0) containing 5 mM 
monothioglycerol and 10% glycerol at 10 mg of protein/ml, and stored 
at -80°C. 
2.5. Solubilization and one-step urification of the TetA protein 
Phospholipids (10 mg/ml, E. coli phospholipids or soybean L-a- 
phosphatidylcholine) w re suspended in 10 mM MES-Tricine (pH 7.0) 
containing 1 mM dithiothreitol using a bath sonicator and stored at 
-80°C. The EDTA-washed inner membranes were solubilized with 
1.25% octylglucoside in the presence of 5 mg/ml E. coli phospholipids 
[28] and then centrifuged at 210,000 × g for 30 rain to remove insoluble 
materials. 
Purification by DEAE-Sepharose CL-6B column chromatography 
was performed as follows: the octylglucoside extract (500/21) was ap- 
plied to a DEAE-Sepharose CL-6B anion exchange column (bed vol- 
ume, 5 ml) equilibrated with 50 mM triethanolamine buffer (pH 8,0) 
containing 0.1% dodecylmaltoside, and eluted with 25 ml of a linear 
gradient of 0-0.5 M NaC1 in 50 mM triethanolamine buffer (pH 8,0) 
containing 0.1% dodecylmaltoside at the flow rate of 1 ml/min. The 
absorbance at280 nm of each fraction (800/21) was monitored and the 
proteins were analyzed by SDS-polyacrylamide g l electrophoresis. Es- 
sentially pure TetA protein was obtained in fractions 16~18 corre- 
sponding to NaCI concentrations of 0.25~).3 M. 
2.6. Immunoblot analysis of the TetA protein 
SDS-polyacrylamide g l electrophoresis of samples containing the 
TetA protein was followed by electroblotting of the protein. The TetA 
protein was detected by means of an enzyme-linked immunosorbent 
assay using an anti-carboxyl-terminal peptide antibody [11] and an 
Express blot assay kit (Bio-Rad), as described in the previous paper 
[12]. 
2.7. Reconstitution of the functional TetA protein in proteoliposomes 
Proteoliposomes were reconstituted by two different methods: 
(l) freeze-thawing dilution, and (2) gel filtration chromatography. Re- 
constitution by freeze-thawing dilution was performed as follows: 100 
/21 (200/2g protein) of an octylglucoside extract or purified TetA protein 
solution was mixed with 100/21 (200/2g protein) of purified FoF~- 
ATPase and 60/21 (60/2g lipid) of briefly bath-sonicated phosphati- 
dylcholine liposomes, followed by freezing and thawing for two times. 
Then the mixture was diluted 50-fold with 13 ml of 10 mM Tricine- 
choline (pH 8.0) containing 0.1 M KC1 and 5 mM MgC12. The reconsti- 
tuted proteoliposomes were collected by ultracentrifugation at
165,000 × g for 60 min using a HITACHI Himac CP 90~, and then 
resuspended in 150/21 of the same buffer and used for the tetracycline 
uptake assay. 
Reconstitution by gel filtration chromatography was performed as 
follows: an octylglucoside-extract or purified TetA solution (500/21, 1.2 
mg of protein) was mixed with FoFrATPase (800/21, 0.8 mg of protein) 
and sonicated liposomes (600/21, 6 mg of phosphatidylcholine), fol-
lowed by freeze-thawing twice, and then the mixture was applied to a 
Sephadex G-25 column (1 cm x 10 cm) equilibrated with 10 mM 
Tricine-choline (pH 8,0) containing 5mM monothioglycerol. The tur- 
bid eluate was collected. After centrifugation at200,000 x g for 30 min 
using a Beckman Optima TL Ultracentrifuge, the reconstituted proteo- 
liposomes were suspended in 800/21 of the same buffer and immediately 
used for the tetracycline uptake assay. 
2.8. [SH] Tetracycline uptake by proteoliposomes 
[3H]Tetracycline uptake by reconstituted proteoliposomes was per- 
formed using a Sephadex G-50 centrifuge column. 30/21 of proteo- 
liposomes was mixed with 30/21 of 10 mM Tricine-choline (pH 8.0) 
containing 0.1 M KCI, 10 mM MgC12, 1/2g/ml valinomycin and 10 rnM 
ATE After 1 rain incubation at 30°C, 90/21 of the same buffer contain- 
ing 10/2M [3H]tetracycline instead of ATP was added. At the indicated 
times, the assay mixture was applied to a Sephadex G-50 centrifuge 
column and centrifuged at 400 x g for 2 min. Radioactivity and protein 
in the effluent were determined. Assays were also carried out in the 
absence of ATP or in the presence of 2.5 mM NADH instead of ATE 
2.9. Proton transloeation i  proteoliposomes 
Proton translocation i proteoliposomes was assayed by measuring 
the fluorescence quenching of acridine orange (excitation, 492 nm; 
emission, 540 nm). Proteoliposomes were reconstituted by the freeze- 
thawing dilution procedure [23]. An octylglucoside-extract or purified 
TetA solution (100/21, 200/2g of protein) was mixed with FoFt (100/21, 
100/2g of protein) and bath-sonicated liposomes (60/21, 600/2g of 
phosphatidylcholine). After freeze-thawing twice, 5~100/21 of the mix- 
ture was diluted with 2 ml of 10 mM Tricine-choline (pH 8.0) containing 
0.1 M KC1, 10 mM MgC12, 0.625/2g/ml valinomycin and 1.25/2M 
acridine orange. Ten/21 of 0.1 M ATP, 10/21 of 2 mM tetracycline, and 
5 pl of 1 M NH4CI were successively added at the indicated times. 
3. Results and discussion 
3. I. Overproduction of  the TetA protein 
The TnlO-tetA gene encoding the metal-tetracycline/H + an- 
(A) 
EcoRI ~ 
(B) 
. . . . . .  l acZ  . . . . . .  / . . . .  te tA  . . . . . . . .  
TCACACAGGAAACAGCTATG ACCATGATTACGAATTCTTCGACAAAG. . .  
SD sequence EcoRI  
2 3 4 5 6 
( Met  ) ThrMet  I leThrAsnSerSerThrLys . . .  
Fig. 1. Structure of the plasmid carrying the tetA gene downstream of 
the lac promoter. (A) Plasmid pSYTET was constructed as described 
in the previous paper [21]. EeoRI* and (EcoRI) indicate the newly 
introduced and removed restriction sites, respectively. (B) The nucleo- 
tide sequence around the lacZ-tetA fusion site and the deduced amino 
acid sequence of the fusion protein. The underlined amino acid residues 
are derived l¥om fl-galactosidase. The numbers of the amino acids are 
the same as in the native TetA protein. 
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Fig. 2. SDS-polyacrylamide g l electrophoresis of various fractions 
from E. coli RB791 cells. Samples prepared from E. coli RB791/ 
pSYTET cells were subjected to SDS polyacrylamide (12%) gel elec- 
trophoresis and stained with Coomassie brilliant Blue. Lane 1, molecu- 
lar weight markers; lane 2, French press vesicles; lane 3, inner mem- 
branes; lane 4, EDTA-washed inner membranes; lane 5, 1.25% octylglu- 
coside-extract; lane 6, TetA protein purified by DEAE-Sepharose 
CL-6B column chromatography. 
tiporter (TetA) was placed downstream of the lac promoter in 
pUC118, and the resulting plasmid designated pSYTET (Fig. 
1A, also see [21]). Since the tetA gene in this plasmid is fused 
inframe to the lacZ gene, the expression of the gene is con- 
trolled by the lac promoter/operator, and 4 amino acid resi- 
dues, Thr-Met-Ile-Thr, derived from LacZ are inserted into the 
N-terminal of the TetA protein (Fig. 1B). The insertion of these 
residues did not affect he tetracycline/H + antiport activity [21]. 
An E. coli strain carrying the inducible (wild-type) lacI gene 
could not be transformed with this plasmid, suggesting that 
overproduction of the TetA protein is lethal for the host cells. 
The E. eoli strain required the lacI q mutation for transforma- 
tion with pSYTET. 
Following 2 h induction of E. coli RB791 cells harboring 
pSYTET with 0.1 mM isopropyl fl-D-thiogalactopyranoside, 
the cells were harvested and fractionated. A dense 36 kDa band 
was observed for the membrane fraction on SDS-poly- 
acrylamide gel electrophoresis (Fig. 2, lane 2), which was iden- 
tified as the TetA protein using anti-TetA-carboxyl-terminal- 
peptide antiserum (data not shown). The TetA protein ac- 
counted for nearly 20% of the total membrane protein, as 
judged using a densitometer. E coil RB791/pSYTET cells pro- 
duced at least 10-fold more TetA protein than RB791/pLGT2 
cells did (data not shown). In addition, cells carrying pSYTET 
expressed a 16 kDa protein, which is probably a degradation 
product of the TetA protein (Fig. 2, lane 2). 
3.2. Solubilization and reconstitution of  the TetA protein 
The membrane fraction was separated into inner and outer 
membrane fractions on a sucrose density gradient. Then the 
inner membrane was washed with a low ionic strength buffer 
containing 0.5 mM EDTA to remove peripheral membrane 
proteins. The TetA protein occupied 21 and 38% of the protein 
in the inner membrane and EDTA-washed inner membrane 
fractions, respectively (Fig. 2, lanes 2 and 3). We used the 
EDTA-washed inner membrane fraction as a starting material 
for solubilization and reconstitution of the TetA protein. 
Solubilization of the EDTA-washed inner membrane frac- 
tion with 1.25% octylglucoside was carried out in the presence 
of 5 mg/ml E. coli phospholipids, as in the case of lactose 
permease [28]. About 40% of the total inner membrane protein 
was recovered in the supernatant on centrifugation. The TetA 
protein comprised about 50% of the octylglucoside-extract pro- 
teins (Fig. 2, lane 4). The octylglucoside-extract wasmixed with 
sonicated liposomes, followed by freezing and thawing. Then 
the mixture was applied to a Sephadex G-25 gel filtration col- 
umn to remove detergents. About 30% of the octylglucoside- 
extract proteins was recovered in the proteoliposomes. 
Through this process, the TetA protein was further concen- 
trated up to about 60% of the proteoliposomal protein (Fig. 3, 
lane 2). Most of the 16 kDa protein and two high molecular 
weight contaminants (about 60 and 70 kDa) were excluded 
from the proteoliposomes. The proteoliposomes were also re- 
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Fig. 3. SDS-polyacrylamide g l electrophoresis of reconstituted proteo- 
liposomes. Proteoliposomes were reconstituted with only the octylglu- 
coside-extract (lane 2), the octylglucoside-extract nd FoFrATPase 
(lane 3), or FoF~-ATPase alone (lane 4) by gel filtration chromatogra- 
phy. Lane 1, molecular weight markers. SDS-polyacrylamide g l elec- 
trophoresis was performed in the same way as in Fig. 2. 
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Fig. 4. [3H]Tetracycline (TC) uptake by reconstituted proteoliposomes. 
(A) Proteoliposomes reconstituted with the TetA protein and FoF: 
ATPase. (B) Proteoliposomes reconstituted with FoF:ATPase alone. 
Reconstitution was performed by the gel filtration chromatography 
method. Assays were performed as described insection 2. Closed circles 
with a solid line and open circles with a dashed line indicate the uptake 
in the presence and absence of ATE respectively. 
constituted in the presence of purified FoF1-ATPase in the same 
way (Fig. 3, lane 3). 
3.3. [3H]Tetracycline uptake by reconstituted proteoliposomes 
[3H]Tetracycline uptake was assayed using a Sephadex G-50 
centrifuge column. Reconstituted proteoliposomes containing 
the TetA protein and FoF:ATPase exhibited substantial 
[3H]tetracycline uptake in an ATP-dependent manner (Fig. 
4A). The initial rate of uptake was 2 nmol/mg protein/min, 
which is comparable to the specific activity in inverted mem- 
brane vesicles. The reason why the specific activity of the recon- 
stituted proteoliposomes was not higher than that in the in- 
verted vesicles may be because a difference in the efficiency of 
energy supply and/or partial inactivation of TetA during the 
solubilization/reconstitution process. NADH-dependent [3H]- 
tetracycline uptake was not observed in the proteoliposomes 
(data not shown), indicating that there was no contamination 
by insoluble inverted membrane vesicles. Proteoliposomes con- 
taining only FoF:ATPase (Fig. 4B) or TetA (data not shown) 
showed no [3H]tetracycline uptake, regardless of the presence 
or absence of ATE These observations clearly indicated that 
the solubilized TetA and FoF:ATPase were integrated in the 
same vesicles and acted in the chemiosmotic coupling. 
Reconstitution was also performed by the freeze-thawing 
dilution procedure [23], and the [3H]tetracycline uptake was 
measured by a rapid filtration method similar to the assay for 
inverted vesicles [2]. ATP-dependent [3H]tetracycline uptake 
was certainly observed (data not shown), but the amount of 
tetracycline actively taken up was significantly less than in the 
case of the column method. 
3.4. Tetracycline-coupled H + translocation in reconstituted 
proteoliposomes 
Proton translocation coupled with tetracycline transport was 
measured by monitoring the fluorescence change of acridine 
orange. Proteoliposomes reconstituted with FoF:ATPase 
alone showed ATP-dependent ApH formation, as judged from 
the fluorescence quenching, but no change in fluorescence in- 
tensity on the addition of tetracycline was observed (Fig. 5A). 
Proteoliposomes reconstituted with the TetA protein and FoF:  
ATPase also showed the formation of ApH through ATP hy- 
drolysis (Fig. 5B). The addition of tetracycline caused a signif- 
icant increase in the fluorescence intensity (Fig. 5B), indicating 
efflux of H* out of the proteoliposomes coupled with the influx 
of tetracycline into them. 
3.5. Effect of sulfhydryl reagent on tetracycline/H + antiport by 
reconstituted proteoliposomes 
The wild-type TetA protein has a cysteine residue at position 
377. However, N-ethylmaleimide (NEM) did not inhibit tetra- 
cycline transport in inverted membrane vesicles containing the 
wild-type TetA protein [10,14], because NEM did not bind to 
Cys377 [14]. In contrast, the activity in vesicles containing the 
Cys65 mutant TetA protein was completely abolished by NEM 
[10,14]. Thus proteoliposomes containing the Cys65 mutant 
TetA protein were prepared in the same way. Tetracycline- 
coupled H + translocation by the wild-type proteoliposomes was 
not affected by NEM (Fig. 5C). In contrast, tetracycline-de- 
pendent H+ etttux in the proteoliposomes containing the Cys65 
mutant TetA protein was completely inhibited (Fig. 5E). These 
results confirm that the tetracycline/H* antiport observed in 
this reconstitution system is certainly mediated by the TetA 
protein. 
3.6. One-step urification of the TetA protein and reconstitution 
of tetracycline-coupled proton translocation from the 
purified TetA protein 
Essentially pure TetA protein was obtained on DEAE- 
Sepharose C1-6B anion exchange column chromatography of 
the solubilized TetA protein (Fig. 2, lane 6). Proteoliposomes 
reconstituted from the purified TetA protein also showed tetra- 
cycline-coupled proton translocation (data not shown). These 
experiments confirmed that no cytoplasmic, periplasmic or per- 
ipheral membrane proteins are required for the tetracycline/H + 
antiport function. 
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Fig. 5. Proton translocation i reconstituted proteoliposomes, Proton 
translocation across proteoliposomes was measured by monitoring the 
fluorescence quenching of acridine orange. Proteoliposomes were re- 
constituted with (A) FoF:ATPase alone. (B and C) the wild-type TetA 
protein and FoF:ATPase. (D and E) the Cys65 mutant TetA protein 
and FoF:ATPase. Reconstitution was performed by the freeze-thawing 
dilution method. ATP (0.5 mM), tetracycline (TC, 1 mM), and NH4CI 
(2.5 mM) were successively added at the indicated times. In (C) and (D), 
proteoliposomes were preincubated with 1 mM NEM for 1 min before 
ATP was added. 
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